Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nebulised heparin as a treatment for lung diseases: formulation challenges and pulmonary drug delivery strategies.

Lung·2026
Same author

IL-1β Pathway Inhibition in Asthma and COPD: Strong Biological Rationale, Disappointing Clinical Trials, and Emerging New Opportunities.

Lung·2026
Same author

The Platelet/Megakaryocyte Axis is Necessary for Allergic Sensitisation and Inflammatory Responses to House Dust Mite in the Lung.

Lung·2026
Same author

The Effect of the Novel Macrolide Glasmacinal (EP395) on Allergen-Induced Eosinophil Infiltration into the Lung.

Lung·2026
Same author

Platelet-specific P2Y<sub>1</sub> receptor deficient mice have suppressed pulmonary leukocyte recruitment in response to lipopolysaccharide.

Respiratory research·2026
Same author

Pseudomonas aeruginosa infection exacerbates elastase induced lung damage: characterisation of a novel murine two-hit model of pulmonary infection.

Respiratory research·2025

Related Experiment Video

Updated: Jun 28, 2026

Isolation of Peritoneum-derived Mast Cells and Their Functional Characterization with Ca2+-imaging and Degranulation Assays
11:31

Isolation of Peritoneum-derived Mast Cells and Their Functional Characterization with Ca2+-imaging and Degranulation Assays

Published on: July 4, 2018

A role for MC3R in modulating lung inflammation.

Stephen J Getting1, Yanira Riffo-Vasquez, Simon Pitchford

  • 1Department of Human and Health Sciences, School of Biosciences, University of Westminster, 115 New Cavendish Street, London W1W 6UW, UK. s.getting@westminster.ac.uk

Pulmonary Pharmacology & Therapeutics
|November 11, 2008
PubMed
Summary
This summary is machine-generated.

Melanocortin peptides, particularly MC3R agonists, show potential as anti-inflammatory therapies for lung inflammation. They reduce leukocyte accumulation in both allergic and non-allergic models by targeting specific receptors.

More Related Videos

An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses
08:16

An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses

Published on: July 7, 2017

Related Experiment Videos

Last Updated: Jun 28, 2026

Isolation of Peritoneum-derived Mast Cells and Their Functional Characterization with Ca2+-imaging and Degranulation Assays
11:31

Isolation of Peritoneum-derived Mast Cells and Their Functional Characterization with Ca2+-imaging and Degranulation Assays

Published on: July 4, 2018

An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses
08:16

An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses

Published on: July 7, 2017

Area of Science:

  • Immunology
  • Pharmacology
  • Molecular Biology

Background:

  • Lung inflammation involves complex immune responses.
  • Melanocortin peptides are known for their diverse physiological roles.
  • Therapeutic strategies for lung inflammation are actively sought.

Purpose of the Study:

  • To investigate melanocortin peptides as potential therapeutics for lung inflammation.
  • To identify the specific melanocortin receptor (MCR) subtypes involved in mediating anti-inflammatory effects.
  • To evaluate the efficacy of MCR agonists in allergic and non-allergic lung inflammation models.

Main Methods:

  • Western blot analysis to detect MCR expression on alveolar macrophages.
  • In vitro assays measuring cAMP levels in macrophages treated with MCR agonists.
  • In vivo studies using mouse models of allergic lung inflammation and LPS-induced neutrophilia.
  • Genetic manipulation (MC3R-null mice, recessive yellow mice) to assess receptor function.

Main Results:

  • Melanocortin receptor types 1 and 3 (MCR1, MCR3) are expressed on alveolar macrophages.
  • Selective MC3R agonists ([D-TRP(8)]-gamma-MSH) and a pan-agonist (alpha-MSH) increased cAMP in wild-type and MC1R-mutant macrophages, but not in MC3R-null macrophages.
  • Alpha-MSH and [D-TRP(8)]-gamma-MSH significantly reduced eosinophil and lymphocyte accumulation in an allergic model, an effect dependent on MC3R.
  • These agonists also attenuated neutrophil accumulation and TNF-alpha release in a non-allergic model.
  • Anti-inflammatory effects were linked to MC3R activation, inhibiting TNF-alpha in non-allergic models but not IL-5 in allergic models.

Conclusions:

  • Melanocortin peptides, via MC3R activation, inhibit leukocyte accumulation in both allergic and non-allergic lung inflammation.
  • Selective MC3R agonists demonstrate potential as novel anti-inflammatory therapeutics for lung inflammatory conditions.
  • The findings highlight MC3R as a key mediator of melanocortin-induced anti-inflammatory effects in the lung.